{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:15:15Z","timestamp":1790154915655,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["9221577201"],"award-info":[{"award-number":["9221577201"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.08.068","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T22:29:01Z","timestamp":1535840941000},"page":"6124-6132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection"],"prefix":"10.1016","volume":"36","author":[{"given":"Mona","family":"Roozbehani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Falak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Razmjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad reza","family":"Meamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Masoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Khoshmirsafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Gharavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.068_b0005","series-title":"Toxoplasmosis of animals and humans","author":"Dubey","year":"2009"},{"key":"10.1016\/j.vaccine.2018.08.068_b0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev-micro-091014-104100","article-title":"Lytic cycle of T. gondii: 15 years later","volume":"69","author":"Blader","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.14202\/vetworld.2017.1063-1065","article-title":"Detection of anti-T. gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients","volume":"10","author":"Gharavi","year":"2017","journal-title":"Vet World"},{"key":"10.1016\/j.vaccine.2018.08.068_b0020","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.vaccine.2010.03.028","article-title":"Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans","volume":"28","author":"Tan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.068_b0025","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-Toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2018.08.068_b0030","doi-asserted-by":"crossref","first-page":"3279e88","DOI":"10.1128\/IAI.00425-12","article-title":"The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden","volume":"80","author":"Grover","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.08.068_b0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1286-4579(03)00048-0","article-title":"Development of a vaccine for toxoplasmosis: current status","volume":"5","author":"Bhopale","year":"2003","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.08.068_b0040","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/j.vaccine.2011.09.016","article-title":"Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B-and T-cell epitopes from T. gondii antigens","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.068_b0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1199284","article-title":"Intramembrane cleavage of AMA1 triggers toxoplasma to switch from an invasive to a replicative mode","volume":"331","author":"Santos","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.08.068_b0050","doi-asserted-by":"crossref","first-page":"632424","DOI":"10.1155\/2008\/632424","article-title":"Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis","volume":"2008","author":"Dlugonska","year":"2008","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pt.2014.12.002","article-title":"Toxoplasma secretory granules: one population or more?","volume":"31","author":"Mercier","year":"2015","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/bioe.21541","article-title":"Recombinant ROP2, ROP4, GRA4 and SAG1 antigen-cocktails as possible tools for immunoprophylaxis of toxoplasmosis: what\u2019s next?","volume":"3","author":"Dziadek","year":"2012","journal-title":"Bioengineered"},{"key":"10.1016\/j.vaccine.2018.08.068_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VDT.S57474","article-title":"Current progress toward vaccines against T. gondii","volume":"4","author":"Garcia","year":"2014","journal-title":"Vaccine Devel Ther"},{"key":"10.1016\/j.vaccine.2018.08.068_b0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.exppara.2011.04.004","article-title":"Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against T. gondii infection","volume":"128","author":"S\u00e1nchez","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/21645515.2015.1102804","article-title":"Peptide\/protein vaccine delivery system based on PLGA particles","volume":"12","author":"Allahyari","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.08.068_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.imlet.2017.03.006","article-title":"Enhancing immune responses to a DNA vaccine encoding T. gondii GRA14 by calcium phosphate nanoparticles as an adjuvant","volume":"185","author":"Ahmadpour","year":"2017","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2018.08.068_b0085","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00436-015-4701-y","article-title":"Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 T. gondii proteins","volume":"114","author":"Grzybowski","year":"2015","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.08.068_b0090","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4161\/hv.26088","article-title":"Advances in the study of HLA-restricted epitope vaccines","volume":"9","author":"Zhao","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.08.068_b0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jmb.2005.09.028","article-title":"Crystal structure of the complex between the monomeric form of T. gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response","volume":"354","author":"Graille","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0100","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s00436-016-5049-7","article-title":"Serodiagnosis of fasciolosis by fast protein liquid chromatography-fractionated excretory\/secretory antigens","volume":"115","author":"Mokhtarian","year":"2016","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.08.068_b0105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.intimp.2015.09.011","article-title":"Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB\/c mice","volume":"29","author":"Salari","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0110","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1007\/s00436-016-5250-8","article-title":"Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces","volume":"115","author":"Naseri","year":"2016","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.08.068_b0115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejpb.2013.06.017","article-title":"Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity","volume":"85","author":"Pawar","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2018.08.068_b0120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00436-011-2296-5","article-title":"Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from T. gondii in mice: cellular and humoral immune responses","volume":"109","author":"Li","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.08.068_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pim.12419","article-title":"Evaluation of the immune response in BALB\/c mice induced by a novel DNA vaccine expressing GRA14 against T. gondii","volume":"39","author":"Ahmadpour","year":"2017","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/icb.1997.63","article-title":"Multi-epitope DNA vaccines","volume":"75","author":"Suhrbier","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0135","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.vaccine.2010.11.015","article-title":"Towards an immunosense vaccine to prevent toxoplasmosis: protective T. gondii epitopes restricted by HLA-A*0201","volume":"29","author":"Cong","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.068_b0140","first-page":"14","article-title":"In silico and in vivo analysis of T. gondii epitopes by correlating survival data with peptide-MHC-I binding affinities","volume":"48","author":"Huang","year":"2016","journal-title":"IJID"},{"key":"10.1016\/j.vaccine.2018.08.068_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2011.10.006","article-title":"T. gondii HLA-B*0702-restricted GRA7(20\u201328) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-gamma and reduces parasite burden in HLA-B*0702 mice","volume":"73","author":"Cong","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0150","doi-asserted-by":"crossref","first-page":"85955","DOI":"10.1172\/jci.insight.85955","article-title":"Adjuvanted multi-epitope vaccines protect HLA-A* 11: 01 transgenic mice against T. gondii","volume":"1","author":"El Bissati","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2018.08.068_b0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against T. gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2018.08.068_b0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3347\/kjp.2014.52.6.581","article-title":"Recent advances in T. gondii immunotherapeutics","volume":"52","author":"Lim","year":"2014","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0165","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"key":"10.1016\/j.vaccine.2018.08.068_b0170","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1016\/j.vaccine.2015.10.077","article-title":"Vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice","volume":"33","author":"Cao","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.068_b0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/1471-2334-14-525","article-title":"Evaluation of immuno-efficacy of a novel DNA vaccine encoding T. gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.068_b0180","first-page":"133","article-title":"The roles of CD4 and CD8 in T cell activation","volume":"3","author":"Miceli","year":"1991","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/imt.11.68","article-title":"The CD8 T-cell road to immunotherapy of toxoplasmosis","volume":"3","author":"Bhadra","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.vaccine.2018.08.068_b0190","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0195","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0020-7519(03)00053-5","article-title":"Recent advances in veterinary vaccine adjuvants","volume":"33","author":"Singh","year":"2003","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0200","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","article-title":"Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with T. gondii","volume":"16","author":"Petersen","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.068_b0205","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12879-016-2147-1","article-title":"Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against T. gondii","volume":"17","author":"Song","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.068_b0210","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","article-title":"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis","volume":"1","author":"Martin","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12879-016-1496-0","article-title":"Vaccination with T. gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.08.068_b0220","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.exppara.2013.04.002","article-title":"Encapsulation of chimeric protein rSAG1\/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against T. gondii in mice","volume":"134","author":"Chuang","year":"2013","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2018.08.068_b0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00436-016-5298-5","article-title":"Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from T. gondii","volume":"116","author":"Nabi","year":"2017","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2018.08.068_b0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.exppara.2016.09.008","article-title":"Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against Toxoplasama gondii","volume":"170","author":"Allahyari","year":"2016","journal-title":"Exp Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T18:02:21Z","timestamp":1604858541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":46,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312088"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}